Buy spinraza nusinersen 12mg 5ml injection
 
Spinraza is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide for treating spinal muscular atrophy (SMA) in pediatric and adult patients.  
 
 Recommended dosage: 
The recommended dosage of Spinraza is 12 mg (5 mL) per administration. Initiate Spinraza treatment with 4 loading doses.
The first three loading doses should be administered at 14-day intervals. The 4th loading dose should be administered 30 days after the 3rd dose.
A maintenance dose should be administered once every 4 months after that.
Spinraza is administered intrathecally by, or under the direction of, healthcare professionals experienced in lumbar punctures.